Atrial fibrillation surgery market projected to grow by $1.99b until 2028

Digital catheterisation labs are anticipated to contribute to market growth.

The global atrial fibrillation surgery market is anticipated to grow by $1.99b until 2028 at an estimated compound annual growth rate (CAGR) of 14.76%.

A report by Technavio revealed that market demand is fuelled by the prevalence of cardiovascular disorders, including myocarditis, rhythm disturbances, acute cardiac shock, acute respiratory distress, and obesity-related heart diseases.

This prevalence, along with an increasing ageing population, has also influenced the growing need for cardiac ablation procedures, which are non-invasive treatments that utilise threading thin, flexible catheters and radio waves to destroy abnormal heart tissues.

Meanwhile, the market is driven by technological advancements with a projected trend towards digital catheterisation laboratories in hospitals.

“Digital cath labs specialise in outpatient diagnostic services in hospitals, ASCs, and physicians' clinics. Combining cardiac catheterisation for ablation procedures and post-procedure recovery areas saves costs,” the report said.

Moreover, atrial fibrillation therapeutics and ablation strategies, such as AVNRT, CathVision, ECGenius System, and ECG diagnosis, serve as additional key trends influencing the market.

“Minimally invasive surgeries, such as the EnCompass Clamp and Isolator Synergy, offer accuracy, speedy recovery, and reduced hospital stay,” the report added.